文献速递胃肠外科

单孔与多孔腹腔镜结肠癌手术多中心随机试验中期分析

Multicenter, randomized single-port versus multiport laparoscopic surgery (SIMPLE) trial in colon cancer: an interim analysis.
PubMed 文献 · Surg Endosc · 2017-09-15

韩国七家医院纳入194例结肠癌患者随机分为单孔腹腔镜组(n=99)与多孔腹腔镜组(n=95),主要终点为术后并发症。中期分析显示两组术后并发症发生率分别为10.8%与12.5%(p=0.714),单孔组中转多孔及开腹率分别为12.9%与2.2%,提示单孔腹腔镜用于结肠癌根治性切除技术安全可行。

要点

  • 单孔与多孔腹腔镜结肠癌术后并发症率相似(10.8% vs 12.5%,p=0.714)。
  • 单孔组中转多孔率为12.9%,中转开腹率为2.2%。
  • 两组手术时间、出血量、淋巴结清扫数及切缘长度无显著差异。

核心结论

  • 中期分析结果提示单孔腹腔镜用于结肠癌根治性切除技术安全且可行。

研究设计与样本

  • 多中心随机对照试验SIMPLE,2011年8月至2014年4月韩国七家医院招募194例结肠癌患者,随机分为单孔组(n=99)与多孔组(n=95)。
  • 主要终点为术后并发症,在入组达50%患者后进行中期分析,评估手术、术后及病理结局。

主要发现

  • 单孔组与多孔组术后并发症发生率分别为10.8%与12.5%(p=0.714)。
  • 单孔组中转多孔腹腔镜率为12.9%,中转开腹率为2.2%。
  • 两组患者人口学特征、手术时间、估计出血量、 harvested淋巴结数及两端切除 margin长度均无显著差异。
  • 两组功能恢复时间、疼痛评分及镇痛药用量相似。

临床怎么用

  • 在具备腹腔镜技术的中心,单孔腹腔镜可作为结肠癌根治性切除的安全术式选择,需注意其中转多孔或开腹的可能。

局限性

  • 本文为中期分析,样本量为194例,仅报告短期围术期结局,长期肿瘤学结果未涉及。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Single-port laparoscopic surgery (SPLS) was recently introduced as an innovative minimally invasive surgery method. Retrospective studies have revealed the safety and feasibility of SPLS for colon cancer treatment. However, no prospective randomized trials have been performed. The multicenter, randomized SIMPLE (single-port versus multiport laparoscopic surgery) trial aimed to investigate short-term perioperative outcomes of SPLS for colon cancer treatment, compared with multiport laparoscopic surgery (MPLS). METHODS: Between August 2011 and April 2014, a total of 194 patients with colon cancer were recruited from seven hospitals in Korea. Patients were randomly allocated into the SPLS group (n = 99) or MPLS group (n = 95). The primary endpoint was postoperative complications. Operative, postoperative, and pathologic outcomes were analyzed after 50% of the patient study population had been recruited. RESULTS: The patients' demographic characteristics, operative times, estimated blood volume losses, numbers of harvested lymph nodes, and lengths of both resection margins were not significantly different between groups. In the SPLS group, the rates of conversion to MPLS and open surgery were 12.9 and 2.2%, respectively. Postoperative complications occurred in 10.8% of the SPLS, and 12.5% of the MPLS patients (p = 0.714). Times to functional recovery, pain scores, and amounts of analgesia were similar between groups. CONCLUSION: The results of this interim analysis suggested that SPLS is technically safe and appropriate when used for radical resection of colon cancer. (ClinicalTrials.gov Identifier: NCT01480128).

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Kang BM, Kim HJ, Kye BH, et al. Multicenter, randomized single-port versus multiport laparoscopic surgery (SIMPLE) trial in colon cancer: an interim analysis. Surg Endosc. 2017. PMID: 28916955. doi:10.1007/s00464-017-5842-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。